academic article

• Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen..  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.  23:785-790. 2012